Lipid formulations of amphotericin B

被引:1
作者
AlAbdely, H [1 ]
Revankar, S [1 ]
Graybill, JR [1 ]
机构
[1] UNIV TEXAS, HLTH SCI CTR, DEPT MED, DIV INFECT DIS, SAN ANTONIO, TX 78204 USA
关键词
D O I
10.1055/s-2008-1070998
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页码:289 / 299
页数:11
相关论文
共 99 条
[1]   TREATMENT OF ASPERGILLOSIS IN LEUKEMIA [J].
ADELMAN, BA ;
BENTMAN, A ;
ROSENTHAL, P ;
SMITH, BR ;
BRIDGES, KR ;
HOLMES, W .
ANNALS OF INTERNAL MEDICINE, 1979, 91 (02) :323-324
[2]  
ADLERMOORE J, 1994, BONE MARROW TRANSPL, V14, pS3
[3]   TREATMENT OF MURINE CANDIDOSIS AND CRYPTOCOCCOSIS WITH A UNILAMELLAR LIPOSOMAL AMPHOTERICIN-B FORMULATION (AMBISOME) [J].
ADLERMOORE, JP ;
CHIANG, SM ;
SATORIUS, A ;
GUERRA, D ;
MCANDREWS, B ;
MCMANUS, EJ ;
PROFFITT, RT .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 28 :63-71
[4]  
ALBERT MM, 1994, J MED VET MYCOL, V32, P467
[5]   DOSE-DEPENDENT ANTIFUNGAL ACTIVITY AND NEPHROTOXICITY OF AMPHOTERICIN-B COLLOIDAL DISPERSION IN EXPERIMENTAL PULMONARY ASPERGILLOSIS [J].
ALLENDE, MC ;
LEE, JW ;
FRANCIS, P ;
GARRETT, K ;
DOLLENBERG, H ;
BERENGUER, J ;
LYMAN, CA ;
PIZZO, PA ;
WALSH, TJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (03) :518-522
[6]  
ALLENDOERFER R, 1992, J MED VET MYCOL, V30, P377
[7]  
Anaissie E, 1995, 35 INT C ANT AG CHEM
[8]  
ANAISSIE EJ, 1995, INT C ANT AG CHEM, V35, P330
[9]  
ANAISSIE EJ, 1992, 34 INT C ANT AG CHEM, pM87
[10]   ACTIVITY OF AMPHOTERICIN-B CHOLESTEROL DISPERSION (AMPHOCIL) IN EXPERIMENTAL VISCERAL LEISHMANIASIS [J].
BERMAN, JD ;
KSIONSKI, G ;
CHAPMAN, WL ;
WAITS, VB ;
HANSON, WL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (09) :1978-1980